跳至主要内容
临床试验/NCT03915171
NCT03915171Unknown不适用

Sensitivity and Specificity of NGS in Detecting bMSI in Patients With Gastric, Duodenal and Small Intestinal Cancer

China Medical University, China1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2019年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
50
试验地点
1
主要终点
Sensitivity and specificity of blood MSI detected by NGS

研究概览

简要总结

To study the sensitivity and specificity of NGS in detecting Microsatellite State in blood and to evaluate its potential application in gastrointestinal cancer.

详细描述

NGS can not only detect tissue samples, but also blood samples. For some inoperable cancer patients, the acquisition of tissue samples is difficult and traumatic. It is of great significance for the diagnosis and treatment of these patients to determine MSI status by blood testing. In addition, the heterogeneity of malignant tumors is usually strong, blood testing can overcome the heterogeneity of tissue, and can dynamically monitor the patient's condition. 50 patients with gastric cancer, duodenal cancer and small intestinal cancer will be enrolled in the study. Among them, 30 patients with MSI-H and 20 patients with MSS confirmed by IHC/PCR.The investigators will use 520 gene panel for NGS sequencing of tissue and blood samples from selected patients to study the sensitivity and specificity of NGS in detecting Microsatellite State in blood.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age (>18 years old).
  • Histologically diagnosed as gastric cancer, duodenal cancer or small intestinal cancer (stage III, stage IV).
  • The status of dMMR/pMMR was confirmed by IHC/PCR.
  • with tissue and blood samples (including ctDNA and white blood cells) that meet the requirements.
  • Agree to provide demographic, medical history, pathological diagnosis, imaging diagnosis, TNM staging, ECOG score and other information.

排除标准

  • Suffering from other malignant tumors at the same time.
  • Others that the investigator consider that is inappropriate for this study.

研究组 & 干预措施

MSI-H

Experimental

IHC/PCR tested as dMMR/ MSI-H

干预措施: Next generation sequencing (Diagnostic Test)

MSS

Experimental

IHC/PCR tested as pMMR/ MSS

干预措施: Next generation sequencing (Diagnostic Test)

结局指标

主要结局

Sensitivity and specificity of blood MSI detected by NGS

时间窗: 1 year

To study the sensitivity and specificity of blood MSI detected by NGS.

次要结局

  • Correlation between MMR gene and other gene mutations(1 year)
  • Ideal sequencing depth of MSI in blood test(1 year)
  • Correlation between MSI status and TMB(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yunpeng Liu

Director

China Medical University, China

研究点 (1)

Loading locations...

相似试验